Laboratory-Developed Monkeypox Tests : Aegis Sciences, ARUP Laboratories, Apostle Diagnostics, California Department of Public Health, CDR Companies, CirrusDx, Clinical Reference Laboratory, Devlab Bio, Discover Labs, Integrity Laboratories, Laboratory Corporation of America Holdings, Madison Core Laboratories, Mako Medical Laboratories, Mayo Clinic, Quest Diagnostics, RapidBio, Shepard Health, Sonic Healthcare, US BioTek Laboratories, and UW Virology Laboratory. Hoffmann-La Roche, Qiagen, Thermo Fisher Scientific, Alpha Diagnostic, AtliaBiosystems, Applied DNA Sciences, BioGX, BIONEER, CERTEST BIOTEC, Co-Diagnostics, CorDx, Creative Biogene, Elabscience Biotechnology, LABNOVATION TECHNOLOGIES, and Seegene. would require USD 7 billion to handle the monkeypox outbreak. In addition, the government took better steps to create awareness, communicate among the LGBTQI+ community, mobilize them, and provide better treatments. The regulatory bodies approved the products faster and increased access to monkeypox testing, further accelerating the U.S. This action improved convenience for patients and healthcare providers across the nation, and the government eased the testing procedures by approving the rapid testing kits for monkeypox. In addition, CDC began shipping the tests to some of the largest commercial laboratory companies (including some of the nation’s largest reference laboratories) to increase monkeypox testing capacity. The CDC has scaled the testing capacity to 78 sites in 48 states, primarily at state public health laboratories, with the capacity to conduct around 10,000 tests per week. From day one of this outbreak, providers had access to a high-quality, FDA-cleared test to detect monkeypox.ĭownload the Free US Monkeypox Testing Market Sample Report: The monkeypox virus was diagnosed through the PCR-based method, like the COVID-19 infection testing, and has helped the government immediately increase the testing and provide treatment to the infected people and contribute to the U.S. healthcare system’s testing capacity and handled outbreaks and pandemics better. monkeypox testing market size was valued at $5.3 Million in 2022. The US Government to Invest in the Future-Ready Diagnostics Segment to Minimize the Monkeypox Cases in the Upcoming Years Europe Monkeypox Testing Market Size (2025)
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |